Jurgen Wunram
CIK 1686744 · View on SEC EDGAR ↗
First SEC filing: Feb. 6, 2018 · Latest: Feb. 6, 2018
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 24, 2017 | DBD | P | 2,000 | $21.94 | $43,880 | 10,740 Direct | +22.88% | Acquired | 210.3% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 1, 2018 | DBD | Non-Qualified Stock Option [F1,F2] | Common Shares (45,953) | $18.75 | Feb. 1, 2028 | 45,953 | Acquired |
| Feb. 1, 2018 | DBD | Non-Qualified Stock Option [F4] | Common Shares (67,428) | $18.75 | Feb. 1, 2028 | 67,428 | Acquired |
| Feb. 8, 2017 | DBD | Non-Qualified Stock Options [F3] | Common Shares (75,356) | $26.60 | Feb. 7, 2027 | 75,356 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | — | — | — | — | $925,357 | — | $116,133 | $1,270,711 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.